Introductory Note
On December 19, 2019, Arotech Corporation (the “Company”), a Delaware corporation, merged (the “Merger”) with Argonaut Merger Sub, Inc. (“Merger Sub”), a Delaware corporation and a direct, wholly-owned subsidiary of Argonaut Intermediate, Inc. (“Parent”), a Delaware corporation, pursuant to the terms and conditions of the Agreement and Plan of Merger, dated September 22, 2019 (the “Merger Agreement”), by and among the Company, Parent and Merger Sub. As a result of the Merger, the Company became a wholly-owned subsidiary of Parent.
Item 2.01 | Completion of Acquisition or Disposition of Assets. |
At the effective time of the Merger (the “Effective Time”), each share (a “Share”) of common stock of the Company, par value $0.01 per share (the “Common Stock”) (other than Cancelled Shares (as defined in the Merger Agreement) and Dissenting Shares (as defined in the Merger Agreement)), issued and outstanding immediately prior to the Effective Time was converted into the right to receive $3.00 in cash, without interest (the “Merger Consideration”).
In addition, at the Effective Time, each restricted stock unit award in respect of Shares that was outstanding immediately prior to the Effective Time (a “Company RSU”) fully vested (including Company RSUs subject to performance-based vesting) and was cancelled and converted automatically into the right to receive an amount in cash, without interest, equal to the product of (i) the amount of the Merger Consideration and (ii) the total number of Shares underlying such Company RSU, net of applicable tax withholding. Also at the Effective Time, all restrictions and vesting requirements with respect to each Share of restricted stock that was outstanding immediately prior to the Effective Time (“Company Restricted Stock”) lapsed and all such shares of Company Restricted Stock vested in full. Each holder of shares of Company Restricted Stock received the Merger Consideration for such shares of Company Restricted Stock.
The aggregate cash consideration paid in the Merger was approximately $80 million, which was funded through proceeds from Parent’s equity financing arrangements obtained in connection with the Merger.
The foregoing description of the Merger Agreement and the Merger in this Current Report onForm 8-K does not purport to be complete and is subject and qualified in its entirety by reference to the full text of the Merger Agreement, which is attached as Exhibit 2.1 to the Company’s Current Report onForm 8-K filed with the Securities and Exchange Commission (the “SEC”) on September 23, 2019 and incorporated herein by reference.
Item 3.01 | Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. |
On December 19, 2019, in connection with the consummation of the Merger, the Company notified the Nasdaq Global Market (“Nasdaq”) of the consummation of the Merger and requested that Nasdaq (i) suspend trading of the Shares on Nasdaq and (ii) file with the SEC a Form 25 Notification of Removal from Listing and/or Registration to delist and deregister the Shares under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company also intends to file with the SEC a Form 15 under the Exchange Act, requesting that the Company’s reporting obligations under Sections 13 and 15(d) of the Exchange Act be suspended.
The information contained in the Introductory Note and Item 2.01 of this Current Report onForm 8-K is incorporated by reference into this Item 3.01.
Item 3.03 | Material Modification to Rights of Security Holders. |
Upon the Effective Time, each holder of Shares issued and outstanding immediately prior to the Effective Time ceased to have any rights as a stockholder of the Company (other than the right, in respect of each of the Shares, to receive the applicable Merger Consideration).